These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 20188858)
1. ICD shocks: not just the "straw that broke the camel's back". Tandri H Heart Rhythm; 2010 Jun; 7(6):761-2. PubMed ID: 20188858 [No Abstract] [Full Text] [Related]
2. The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Bhavnani SP; Kluger J; Coleman CI; White CM; Guertin D; Shafi NA; Yarlagadda RK; Clyne CA Heart Rhythm; 2010 Jun; 7(6):755-60. PubMed ID: 20211275 [TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart". Böcker D; Breithardt G Am J Cardiol; 1999 Mar; 83(5B):83D-87D. PubMed ID: 10089846 [TBL] [Abstract][Full Text] [Related]
4. Treatable causes of sudden death: not really "treatable" or not really the cause? Viskin S; Halkin A; Olgin JE J Am Coll Cardiol; 2001 Nov; 38(6):1725-7. PubMed ID: 11704387 [No Abstract] [Full Text] [Related]
5. M cells in the human heart. Antzelevitch C Circ Res; 2010 Mar; 106(5):815-7. PubMed ID: 20299671 [No Abstract] [Full Text] [Related]
6. Ventricular arrhythmias in patients with implanted cardioverter defibrillators. John RM; Stevenson WG Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094 [TBL] [Abstract][Full Text] [Related]
7. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study. Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM; Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132 [TBL] [Abstract][Full Text] [Related]
8. Over 10 years with an implantable cardioverter-defibrillator - a long term follow-up of 60 patients. Sterliński M; Przybylski A; Gepner K; Syska P; Maciag A; Lewandowski M; Kowalik I; Pytkowski M; Sitkowska-Rysiak E; Lichomski J; Szwed H; Sadowski Z Kardiol Pol; 2010 Sep; 68(9):1023-9. PubMed ID: 20859894 [TBL] [Abstract][Full Text] [Related]
9. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device. Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875 [TBL] [Abstract][Full Text] [Related]
18. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators. Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970 [TBL] [Abstract][Full Text] [Related]
19. Applicability of the MADIT-CRT Response Score for Prediction of Long-Term Clinical and Arrhythmic Events by QRS Morphology. Younis A; Goldenberg M; Kutyifa V; Polonsky B; Mcnitt S; Zareba W; Golovchiner G; Aktas MK; Barsheshet A Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e008499. PubMed ID: 32701367 [No Abstract] [Full Text] [Related]
20. Overview of trends in the control of cardiac arrhythmia: past and future. Singh BN Am J Cardiol; 1999 Nov; 84(9A):3R-10R. PubMed ID: 10568654 [No Abstract] [Full Text] [Related] [Next] [New Search]